Literature DB >> 8058631

The contribution of intestinal secretion to the dose-dependent absorption of celiprolol.

S M Kuo1, B R Whitby, P Artursson, J A Ziemniak.   

Abstract

The contribution of the intestine to the nonlinear absorption of celiprolol in the rat was studied. After intravenous administration of 14C-celiprolol to bile duct-cannulated rats, approximately 9% of the dose was found to be associated with intestinal tissue and its contents. Microhistoautoradiography of frozen intestinal sections showed a time-dependent secretion of celiprolol from the blood into the lumen of the rat intestine. Propranolol, a lipophilic beta-blocker, was also found to be secreted into the intestine in vivo and transported in epithelial cells in both a temperature- and a pH-dependent manner, although to a lesser extent than celiprolol. Consistent with the observations in rats, transport of celiprolol from the basal-lateral to the apical side was found to dominate apical-to-basal transport using human Caco-2 cell monolayers. Additionally, using isolated rat small intestinal epithelial cells, celiprolol was found also to have a time- and temperature-dependent uptake, suggesting the involvement of a carrier-mediated system in its uptake. The uptake was inhibited by 2 mM celiprolol and propranolol and was also found to be pH dependent. Saturation of the carrier-mediated secretion of celiprolol in the intestine may result in enhanced absorption of celiprolol at high doses and account for its observed nonlinear absorption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058631     DOI: 10.1023/a:1018959809352

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  pH regulation in ileum: Na(+)-H+ and Cl(-)-HCO3- exchange in isolated crypt and villus cells.

Authors:  U Sundaram; R G Knickelbein; J W Dobbins
Journal:  Am J Physiol       Date:  1991-03

2.  Na+/HCO3-co-transport in basolateral membrane vesicles isolated from rabbit renal cortex.

Authors:  S M Grassl; P S Aronson
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

3.  The absorption of beta-adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity.

Authors:  D C Taylor; R Pownall; W Burke
Journal:  J Pharm Pharmacol       Date:  1985-04       Impact factor: 3.765

4.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

5.  Elimination of drugs by active intestinal transport.

Authors:  C F George; B S Gruchy
Journal:  J Pharm Pharmacol       Date:  1979-09       Impact factor: 3.765

6.  Determination of total protein.

Authors:  G L Peterson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat.

Authors:  H Lennernäs; C G Regårdh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

8.  Tetraethylammonium transport in renal brush border membrane vesicles of the rabbit.

Authors:  C Rafizadeh; F Roch-Ramel; C Schäli
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

9.  The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa.

Authors:  S Hsing; Z Gatmaitan; I M Arias
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

10.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

View more
  6 in total

1.  Transepithelial transport of diphenhydramine across monolayers of the human intestinal epithelial cell line Caco-2.

Authors:  H Mizuuchi; T Katsura; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

Review 2.  Drug exsorption from blood into the gastrointestinal tract.

Authors:  K Arimori; M Nakano
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

3.  Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.

Authors:  U Wetterich; H Spahn-Langguth; E Mutschler; B Terhaag; W Rösch; P Langguth
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

4.  Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism.

Authors:  K Bleasby; S Chauhan; C D Brown
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs.

Authors:  E Lipka; I D Lee; P Langguth; H Spahn-Langguth; E Mutschler; G L Amidon
Journal:  J Pharmacokinet Biopharm       Date:  1995-06

6.  Rifampicin reduces plasma concentrations of celiprolol.

Authors:  J J Lilja; M Niemi; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2003-11-12       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.